3. Chronic Kidney Disease after Vascularized Composite Allotransplantation
Gabriel Ouellet(Hospices Civils de Lyon), Palmina Petruzzo(University of Cagliari), Jean Kanitakis(Hôpital Lyon Sud), Dorota Kamińska(Wrocław University of Science and Technology), Özlenen Doğan(Akdeniz University), Aram Gazarian(Clinique Ambroise Paré), Claudia Sardu(University of Cagliari), Simon G. Talbot(Brigham and Women's Hospital), Christina L. Kaufman(University of Louisville), Hatem Amer(Mayo Clinic), Luis Landín(Hospital Universitario La Paz), Paolo Sassu(Sahlgrenska University Hospital), Olivier Thaunat(Université Claude Bernard Lyon 1), Kodi Azari(University of California, Los Angeles), Annemarie Weißenbacher(Innsbruck Medical University), Gerald Brandacher(Innsbruck Medical University), Patrik Lassus(University of Helsinki), Martín Iglesias Morales(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Linda C. Cendales(Emory University), Lionel Badet(Université Claude Bernard Lyon 1), Scott L. Levin(University of Pennsylvania), Christophe Gaillard(Hospices Civils de Lyon), Emmanuel Morélon(Université Claude Bernard Lyon 1), Marco Lanzettà(Italian Institute of Technology), Nilesh G. Satbhai(Global Hospitals)
Cited by 0
Related Papers
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k
The promise of organ and tissue preservation to transform medicine
|Nature Biotechnology|2017|530
The International Registry on Hand and Composite Tissue Transplantation
|Transplantation|2008|410
Banff 2011 Meeting Report: New Concepts in Antibody-Mediated Rejection
|American Journal of Transplantation|2012|395
Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2
|Nature Genetics|2003|389